Democratic Underground Latest Greatest Lobby Journals Search Options Help Login
Google

How to solve the prescription drug problem

Printer-friendly format Printer-friendly format
Printer-friendly format Email this thread to a friend
Printer-friendly format Bookmark this thread
This topic is archived.
Home » Discuss » Archives » General Discussion (Through 2005) Donate to DU
 
zoidberg Donating Member (508 posts) Send PM | Profile | Ignore Fri Aug-22-03 08:53 AM
Original message
How to solve the prescription drug problem
http://www.washingtonpost.com/wp-dyn/articles/A29306-2003Aug21.html

Great editorial on a prescription drug pricing idea in the Washinton Post today by a Northwestern University professor. The problem today with prescription drugs is that they are priced at a level that many people simply can't afford. But if we impose limits on what drug companies can charge, they will have a hard time recouping the massive R&D costs associated with creating a new drug. People can wail about drug companies making profits all they want, but the fact is that without proper incentives, no new drugs will be developed (NIH funding is a fraction of private R&D). In reality, drug companies make money from creating the idea for new drugs. The actual production of the drugs is quite mundane, but that is where the revenue comes from. So here is the solution:

First, massive awards would be made to the developers of safe and effective new patented pharmaceuticals. In effect, government would purchase drug patents; developers of successful new drugs would be rewarded for successful R&D. Second, use of the patents would be freely offered to any firms wishing to produce the pills. This would ensure active competition among generic producers and low prices, as competition forced prices down toward their low marginal production cost.
The two elements of the process, R&D and pill production, would be separated. Consumers would get low prices, and innovators would get financial awards.


There are some major potential problems with the impementation of this program (determining the size of the award, making sure the system isn't abused...), but there is no reason why the details can't be worked out. Would it be too expensive? Does this reek of corporate welfare? Should government scientists research all new drugs? What do you think?
Printer Friendly | Permalink |  | Top
ret5hd Donating Member (1000+ posts) Send PM | Profile | Ignore Fri Aug-22-03 09:23 AM
Response to Original message
1. The REAL problem is not R&D costs...
the pharma companies spend more on advertising drugs (that are only available by prescripton) than they do on R&D.

banning the advertising of prescription drugs to consumers would solve the problem
Printer Friendly | Permalink |  | Top
 
zoidberg Donating Member (508 posts) Send PM | Profile | Ignore Fri Aug-22-03 09:38 AM
Response to Reply #1
2. How would that solve the problem?
A company only advertises if they think it will be profitable to do so. So you ban advertising, you reduce profits and reduce incentives to create new drugs. If you banned advertising and could somehow give all the savings in costs to the consumer, prescription drug costs would still be too high for many. Drug companies spend $32 billion in R&D in 2002 (http://www.phrma.org/issues/researchdev/ - a biased site, but I doubt they would outright lie on a number that could be verified). That's a huge cost to be recouped in the price of drugs.

Besides, advertising has some merit to it.
Printer Friendly | Permalink |  | Top
 
ret5hd Donating Member (1000+ posts) Send PM | Profile | Ignore Fri Aug-22-03 09:49 AM
Response to Reply #2
4. advertising has some merit, agreed...
but not to the (medically) uneducated.

let them advertise to the ones with the knowledge and training to decide if a drug is applicable--the physician (unless you are touting the position that people should have access at any time to any drug they wish, which i could agree with, but let's start with marijuana)

and i am not diputing the $32B figure, but their advertising budget is larger.
Printer Friendly | Permalink |  | Top
 
TAH6988 Donating Member (1000+ posts) Send PM | Profile | Ignore Fri Aug-22-03 10:10 AM
Response to Reply #4
5. Really?
What is it?
Printer Friendly | Permalink |  | Top
 
calm_blue_ocean Donating Member (370 posts) Send PM | Profile | Ignore Fri Aug-22-03 09:40 AM
Response to Reply #1
3. Another idea
Have a drug patent expire when profit on the drug reaches some multiple of the R&D costs that were spent on the drug.

In this scheme, the tough issues would be: (1) setting a fair multiple; (2) tracking R&D costs; and (3) tracking profits.

Despite the difficulties, this plan is nice because it correlates research risk and patent reward in a transparent manner. If drug research falls off, then you up the multiple. If we have steady drug research, then you slowly shave the multiple until drug research is negatively impacted.
Printer Friendly | Permalink |  | Top
 
DU AdBot (1000+ posts) Click to send private message to this author Click to view 
this author's profile Click to add 
this author to your buddy list Click to add 
this author to your Ignore list Mon May 06th 2024, 09:08 PM
Response to Original message
Advertisements [?]
 Top

Home » Discuss » Archives » General Discussion (Through 2005) Donate to DU

Powered by DCForum+ Version 1.1 Copyright 1997-2002 DCScripts.com
Software has been extensively modified by the DU administrators


Important Notices: By participating on this discussion board, visitors agree to abide by the rules outlined on our Rules page. Messages posted on the Democratic Underground Discussion Forums are the opinions of the individuals who post them, and do not necessarily represent the opinions of Democratic Underground, LLC.

Home  |  Discussion Forums  |  Journals |  Store  |  Donate

About DU  |  Contact Us  |  Privacy Policy

Got a message for Democratic Underground? Click here to send us a message.

© 2001 - 2011 Democratic Underground, LLC